Type 2 Diabetes Mellitus

• CLINICAL_TRIALS trial_result · 2017-01-31
  Clinical Trial Update: Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin [Phase 2]

  A Phase 2 study comparing the investigational PF-04937319 to glimepiride in adults with type 2 diabetes on metformin completed, with results…

• CLINICAL_TRIALS trial_result · 2017-01-31
  Clinical Trial Update: Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes [Phase 3]

  A Phase 3 head-to-head trial compared insulin detemir with insulin glargine in adults with type 2 diabetes; the study has completed.

• CLINICAL_TRIALS trial_result · 2017-01-31
  Clinical Trial Update: Efficacy and Safety of Levemir® Used as Basal Insulin

  This update reports the efficacy and safety results of using Levemir (insulin detemir) as basal insulin in people with diabetes.

• CLINICAL_TRIALS trial_result · 2017-01-31
  Clinical Trial Update: Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes [Phase 2]

  Phase 2 trial evaluating the safety and efficacy of the investigational drug PF04937319 in patients with Type 2 Diabetes Mellitus; the study…

• CLINICAL_TRIALS research · 2017-01-31
  Clinical Trial Update: Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®

  An observational study of type 2 diabetes patients failing on oral agents who were started on Levemir or Insulatard; the study status is com…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2017-01-31
  Clinical Trial Update: Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

  An observational study completed by Novo Nordisk describes conditions for administering a slow-acting insulin analogue with oral antidiabeti…

• CLINICAL_TRIALS research · 2017-01-31
  Clinical Trial Update: An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

  Observational study update of patients with Type 1 or Type 2 diabetes treated with NovoMix 30 or Levemir.

• CLINICAL_TRIALS trial_result · 2017-01-31
  Clinical Trial Update: Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes [Phase 4]

  This document provides a Phase 4 clinical trial update comparing self-adjusted treatment to standard-of-care treatment in adults with Type 2…

• CLINICAL_TRIALS trial_result · 2017-01-31
  Clinical Trial Update: Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos

  This completed observational study evaluated the predictability of Levemir (insulin detemir) in terms of metabolic control, changes in body …

• CLINICAL_TRIALS trial_result · 2017-01-30
  Clinical Trial Update: Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D [Phase 3]

  A Phase 3 trial update evaluating whether adding a DPP-4 inhibitor to existing incretin mimetic therapy improves glycemic outcomes in patien…

• CLINICAL_TRIALS trial_result · 2017-01-30
  Clinical Trial Update: Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes [Phase 3]

  Phase 3 trial comparing morning vs evening dosing of insulin detemir and an evening NPH insulin regimen in patients with Type 2 diabetes com…

• CLINICAL_TRIALS trial_result · 2017-01-30
  Clinical Trial Update: A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes [Phase 3]

  Phase 3 trial comparing safety and efficacy of insulin degludec versus insulin glargine, with or without oral antidiabetic drugs, in adults …

• CLINICAL_TRIALS trial_result · 2017-01-30
  Clinical Trial Update: Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients [Phase 2]

  Phase 2 trial evaluating lixisenatide on postprandial lipid response in obese patients with Type 2 Diabetes Mellitus; the study status is te…

• FDA approval · 2017-01-27
  FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)

  FDA approved a supplemental application for TRULICITY (dulaglutide) from Eli Lilly, indicating an approved addition to the existing labeling…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes [Phase 3]

  A Phase 3 trial evaluated the safety and efficacy of insulin detemir in combination with oral antidiabetic drugs in patients with type 2 dia…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone [Phase 3]

  This completed Phase 3 trial evaluated the efficacy and safety of insulin detemir added to oral hypoglycemic therapy in adults with type 2 d…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650 [Phase 3]

  This Clinical Trial Update reports that the Phase 3 cardiovascular outcomes study of ITCA 650 in type 2 diabetes mellitus has completed.

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes [Phase 3]

  A Phase 3 trial comparing insulin detemir plus insulin aspart against insulin glargine plus insulin aspart in adults with Type 2 diabetes ha…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes [Phase 3]

  Phase 3 trial comparing insulin detemir versus insulin glargine as add-on therapy to oral antidiabetic drugs in type 2 diabetes has complete…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes. [Phase 4]

  Phase 4 trial evaluating BYDUREON on 24-hour glucose control in metformin-treated type 2 diabetes patients; the study is completed with resu…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes [Phase 1]

  Phase 1 study evaluating the pharmacodynamics and pharmacokinetics of insulin detemir in adults with Type 2 diabetes mellitus.

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes [Phase 3]

  A Phase 3 trial evaluating the safety and efficacy of insulin detemir in combination with oral antidiabetic drugs in adults with Type 2 diab…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients [Phase 2]

  Phase 2 trial assessing the combined impact of Omega-3 carboxylic acids and dapagliflozin on liver fat content in patients with type 2 diabe…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes [Phase 1]

  A Phase 1 study evaluating the pharmacokinetics of insulin detemir in subjects with Type 2 diabetes.

• CLINICAL_TRIALS trial_result · 2017-01-26
  Clinical Trial Update: Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes [Phase 3]

  Phase 3 trial evaluating liraglutide for improving blood glucose control in adults with Type 2 diabetes has completed.